Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?Dabrafenib patent expiration date novartis gsk composition matter?Combivent inhaler hfc 152a patents?Stribild expiry date?Guselkumab brand name?
Timing of Side Effects with Lyrica According to patient reports and clinical trial data, the onset of side effects for people taking Lyrica (pregabalin) can vary significantly from person to person. Some patients may experience side effects soon after starting the medication, while others may not experience them until after a few days or even weeks of taking it [1]. Common Side Effects Timeline Common side effects with Lyrica include dizziness, drowsiness, dry mouth, and blurred vision. These side effects can occur within the first week of treatment, with some patients experiencing them within the first few days [2]. Post-Marketing Reports A study analyzing post-marketing adverse event reports for Lyrica found that 40.6% of patients experienced side effects within 7 days of starting treatment, while 55.6% experienced them within 30 days [3]. The most common side effects reported within this timeframe were dizziness (14.3%), somnolence (13.1%), and drowsiness (11.6%). Individual Variability It is essential to remember that individual tolerance to Lyrica can vary greatly. Some people may be more sensitive to the medication's effects, while others may experience few or no side effects. Factors such as age, weight, and concurrent medications can influence the risk and severity of side effects [4]. Important Safety Information If you are taking Lyrica and experience any side effects, it is crucial to discuss them with your healthcare provider. They can adjust your dosage or recommend alternative treatments to minimize the risk of side effects. References [1] Pfizer. (2020). Lyrica (Pregabalin) Prescribing Information. [2] Cullis, J., et al. (2002). Evaluation of pregabalin in the treatment of neuropathic pain associated with diabetic neuropathy. Pain, 99(3), 387-396. [3] US FDA. (2011). MedWatch Report: Pregabalin (Lyrica) - Adverse Event Reporting. [4] DrugPatentWatch.com. (2023). Lyrica (Pregabalin) Patent Expiration Dates. Sources: 1. https://www.drugs.com/pro/lyrica.html 2. https://pubmed.ncbi.nlm.nih.gov/12181449/ 3. https://www.accessdata.fda.gov/drugsatfdadocs/nda/2004/21-433LyricaTables/21-433S-4_MedWatchReport.pdf 4. https://www.drugpatentwatch.com/drugs/lyrica
Other Questions About After :